Thrombus formation on an atrial septal defect closure device: a case report and review of the literature
- PMID: 16337834
- DOI: 10.1016/j.euje.2005.10.011
Thrombus formation on an atrial septal defect closure device: a case report and review of the literature
Abstract
We report on a case of a mobile left atrial thrombus formation on an atrial septal defect occluder system (28 mm StarFLEX-Occluder) despite 6 months of postprocedural anticoagulation with phenprocoumon and platelet antiaggregation with aspirin in a 69-year-old woman. The closure was performed because of a significant left to right atrial shunt (Qp/Qs 1.8) with enlargement of the right atrial and ventricular cavities and impairment of right ventricular function in the presence of persistent atrial fibrillation and chronic heart failure (NYHA II-III). The 6-month follow up by transoesophageal echocardiography (TEE) revealed the floating thrombus located at the left atrial side of the occluder.
Similar articles
-
ASD device embolization: caught in the act.Echocardiography. 2013 Aug;30(7):E218-9. doi: 10.1111/echo.12206. Epub 2013 Apr 5. Echocardiography. 2013. PMID: 23557356 No abstract available.
-
[Early results of atrial septal defect closure with the Amplatzer Septal Occluder are impacted by tricuspid insufficiency].Przegl Lek. 2004;61(6):644-6. Przegl Lek. 2004. PMID: 15724655 Polish.
-
Device dislocation, probably due to paroxysmal coughing early after percutaneous closure of secundum type atrial septal defect.Am J Cardiol. 2008 Feb 15;101(4):548-9. doi: 10.1016/j.amjcard.2007.08.059. Epub 2007 Dec 20. Am J Cardiol. 2008. PMID: 18312776
-
Right ventricular infarction complicated by right to left shunting through an atrial septal defect: successful treatment with an Amplatzer septal occluder.Heart. 2005 Apr;91(4):e28. doi: 10.1136/hrt.2004.052100. Heart. 2005. PMID: 15772177 Free PMC article. Review.
-
Analysis of factors related to successful transcatheter closure of secundum atrial septal defects using the HELEX septal occluder.Am Heart J. 2006 May;151(5):1129.e7-11. doi: 10.1016/j.ahj.2006.01.005. Am Heart J. 2006. PMID: 16644351 Review.
Cited by
-
Bioabsorbable atrial septal occluder for percutaneous closure of atrial septal defect in children.Tex Heart Inst J. 2012;39(2):184-9. Tex Heart Inst J. 2012. PMID: 22740729 Free PMC article.
-
Recurrent stroke secondary to late patent foramen ovale-closure device thrombus: a case report.Eur Heart J Case Rep. 2021 Aug 4;5(8):ytab313. doi: 10.1093/ehjcr/ytab313. eCollection 2021 Aug. Eur Heart J Case Rep. 2021. PMID: 34423249 Free PMC article.
-
Evaluation of endothelialization of an occluder device with cardiac computed tomography and assessment of the pathological validation.PLoS One. 2025 Jan 10;20(1):e0316638. doi: 10.1371/journal.pone.0316638. eCollection 2025. PLoS One. 2025. PMID: 39792933 Free PMC article.
-
De novo thrombus on an atrial septal defect device 3 years after its implantation.Pediatr Cardiol. 2013 Jun;34(5):1269-71. doi: 10.1007/s00246-012-0379-4. Epub 2012 Jun 19. Pediatr Cardiol. 2013. PMID: 22710725
-
Cardiac remodeling and effects on exercise capacity after interventional closure of atrial septal defects in different adult age groups.Clin Res Cardiol. 2010 Mar;99(3):183-91. doi: 10.1007/s00392-009-0105-2. Clin Res Cardiol. 2010. PMID: 20058016